HaloPROTAC-E
HaloPROTAC-E is a potent Halo PROTAC degrader that reversibly induces degradation of two Halo-tagged endoplasmic reticulum-localized proteins, SGK3 and VPS34, with a DC50 of 3-10 nM. HaloPROTAC-E significantly and selectively induces degradation of endogenous VPS34 complexes (VPS34, VPS15, Beclin1, and ATG14) labeled with Halo and inhibits autophagy.
Product Specifications
CAS Number
[2365478-58-4]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Autophagy; PROTACs; SGK
Type
Reference compound
Related Pathways
Autophagy; Metabolic Enzyme/Protease; PROTAC
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/haloprotac-e.html
Purity
98.76
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1(CC1)C#N)N[C@@H](C(C)(C)C)C(N(C[C@@H]2O)[C@@H](C2)C(NCC(C=CC(C(SC=N3)=C3C)=C4)=C4OCCOCCOCCOCCCCCCCl)=O)=O
Molecular Formula
C39H56ClN5O8S
Molecular Weight
790.41
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
KCTD20, CT (KCTD20, C6orf69, BTB/POZ domain-containing protein KCTD20) (MaxLight 750) discontinued
